Idiopathic inflammatory myopathies: one year in review 2023.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 29 01 2024
accepted: 07 02 2024
medline: 18 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: ppublish

Résumé

Idiopathic inflammatory myopathies are a group of rare, autoimmune, diseases typically involving striate muscle and also variously affecting several other systems or organs, such as joints, skin, lungs, heart and gastrointestinal tract. IIM are mainly characterised by subacute onset and chronic course and are burdened by significant morbidity and mortality. Despite the rarity of these conditions, several efforts have been undertaken in the last years to better understand their pathogenesis, as well as to achieve a more precise classification and to define the optimal therapeutic approach. The aim of this review is to provide an up-to-date digest of the most relevant studies published on this topic over the last year.

Identifiants

pubmed: 38488099
pii: 20853
doi: 10.55563/clinexprheumatol/dh5o6c
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-224

Auteurs

Edoardo Conticini (E)

Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Italy.

Eduardo Dourado (E)

Rheumatology Department, Unidade Local de Saúde da Região de Aveiro; Aveiro Rheumatology Research Center, Egas Moniz Health Alliance; and Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal.

Francesca Bottazzi (F)

Department of Internal Medicine and Therapeutics, Università di Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Chiara Cardelli (C)

Rheumatology Unit, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.

Lorenza Bruno (L)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Jens Schmidt (J)

Department of Neurology and Pain Treatment, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, and Department of Neurology, Neuromuscular Centre, University Medical Centre Göttingen, Germany.

Linda Carli (L)

Rheumatology Unit, University of Pisa, Italy.

Lorenzo Cavagna (L)

Department of Internal Medicine and Therapeutics, Università di Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Simone Barsotti (S)

Rheumatology Outpatient Clinic and Internal Medicine, Livorno Hospital, Italy. simone.barsotti.pisa@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH